Finance

Beta
Lists
524494:BOM
IPCA Laboratories Ltd
₹1,918.90
+1.46%
(+27.65) 1D
Jul 17, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524494...
Open
₹1,888.95
High
₹1,941.40
Low
₹1,846.00
Mkt. cap
487.11B
Avg. vol.
55.58K
Volume
12.28K
Dividend
0.31%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
42.66
52-wk high
₹1,941.40
52-wk low
₹1,252.95
EPS
₹44.98
Shares outstanding
126.35M
No. of employees
17K
Open
₹1,888.95
High
₹1,941.40
Low
₹1,846.00
Mkt. cap
487.11B
Avg. vol.
55.58K
Volume
12.28K
Dividend
0.31%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
42.66
52-wk high
₹1,941.40
52-wk low
₹1,252.95
EPS
₹44.98
Shares outstanding
126.35M
No. of employees
17K
News stories
From sources across the web
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
About IPCA Laboratories Ltd
CEO-
Employees17.2K
FoundedOct 19, 1949
Headquarters-
SectorPharmaceutical industry
Websiteipca.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
23.09B
25.56B
23.92B
23.89B
Cost of goods sold
6.92B
7.82B
6.58B
10.31B
Cost of revenue
6.92B
7.82B
6.58B
10.31B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.43B
5.38B
5.46B
5.54B
Operating expense
13.01B
13.33B
13.09B
9.17B
Total operating expenses
19.92B
21.15B
19.67B
19.48B
Operating income
3.16B
4.42B
4.26B
4.41B
Other non operating income
326.60M
278.60M
201.90M
-680.30M
EBT including unusual items
3.29B
3.89B
4.46B
4.02B
EBT excluding unusual items
3.29B
4.47B
4.28B
3.62B
Income tax expense
960.90M
1.08B
819.30M
950.50M
Effective tax rate
29.21%
27.81%
18.39%
23.66%
Other operating expenses
6.58B
6.92B
6.55B
2.56B
Net income
2.33B
2.83B
3.26B
2.99B
Net profit margin
10.10%
11.05%
13.64%
12.52%
Earnings per share
9.19
12.35
12.09
13.31
Interest and investment income
-
-
-
317.20M
Interest expense
-185.10M
-196.10M
-176.20M
-199.90M
Net interest expenses
-185.10M
-196.10M
-176.20M
117.30M
Depreciation and amortization charges
1.00B
1.03B
1.08B
1.04B
EBITDA
4.09B
5.43B
5.18B
5.37B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more